MA

Vaidya Sane Ayurved Laboratories LtdNSE MADHAVBAUG Stock Report

Last reporting period 30 Sep, 2023

Updated 05 Nov, 2024

Last price

Market cap $B

0.013

Micro

Exchange

XNSE - National Stock Exchange Of India

MADHAVBAUG.NS Stock Analysis

MA

Uncovered

Vaidya Sane Ayurved Laboratories Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

0.013

Dividend yield

0.15 %

Shares outstanding

10.513 B

Vaidya Sane Ayurved Laboratories Ltd is a IN-based company operating in Health Care Providers & Services industry. The company is headquartered in Thane, Maharashtra and currently employs 632 full-time employees. The company went IPO on 2022-02-23. Vaidya Sane Ayurved Laboratories Limited is an India-based company, which is engaged in research and development in ayurvedic medicines and the sale of ayurvedic medicines and products through its various franchises and own clinics. The firm is involved in providing ayurved medical professional services across its various clinics, including panchkarma and other ayurvedic treatments through the running of ayurvedic hospitals. The company uses diagnostics, diet, physiotherapy and ayurveda to provide heart disease, diabetes, hypertension and obesity reversal treatments to its patients. The firm operates approximately 337 clinics across Maharashtra, Madhya Pradesh, Gujarat, Uttar Pradesh, Goa, Karnataka, Delhi, Haryana, Punjab, Himachal Pradesh, Uttarakhand, West Bengal, Jammu, Kerala, Orissa and Chhattisgarh. The company owns about 55 clinics, 59 are OPD's and Mini Clinic and 223 are franchise clinics. The firm operates two cardiac prevention and rehabilitation hospitals in Khopoli and Nagpur.

View Section: Eyestock Rating